By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Oraya Therapeutics 

8000 Jarvis Avenue

Newark  California  94560  U.S.A.
Phone: 510-456-3700 Fax: n/a


SEARCH JOBS


Industry
Biotechnology

Segment
Start Up





Company News
Oraya Therapeutics Announces Rapid Expansion In Europe As More Hospitals Offer Oraya Therapy For Treating Wet AMD 7/22/2014 9:37:14 AM
Oraya Therapeutics Release: Initial Three-Year Data From INTREPID Study Of Non-invasive Therapy For Wet AMD Presented At American Academy of Ophthalmology Annual Meeting 11/18/2013 10:33:25 AM
Oraya Therapeutics Release: Initial Three-Year Data From INTREPID Study Of Non-invasive Therapy For Wet AMD Presented At American Academy of Ophthalmology Annual Meeting 11/18/2013 6:37:46 AM
Oraya Therapeutics And OnCore Manufacturing Complete Production Of Innovative Device For Wet Age-Related Macular Degeneration 11/12/2013 10:13:37 AM
Oraya Therapeutics INTREPID Study Demonstrates Two-Year Safety and Effectiveness of Non-Invasive Therapy for Wet AMD 9/25/2013 9:42:50 AM
Oraya Therapeutics' INTREPID Study Published in Ophthalmology, the Official Journal of the American Academy of Ophthalmology 4/18/2013 8:57:48 AM
New Therapy for Wet AMD Introduced in Switzerland by Oraya Therapeutics and EyeRAD 4/4/2013 12:03:15 PM
Oraya Therapeutics's Successful INTREPID Study Outcomes Presented at EURETINA 2012 Congress 9/21/2012 9:40:33 AM
Oraya Therapeutics Achieves Successful INTREPID Study Outcomes with a Non-Invasive Radiation Therapy for Wet AMD 5/3/2012 10:34:01 AM
Oraya Therapeutics Completes Enrollment in Pioneering Sham-Controlled Study of Radiation Therapy for Wet AMD 5/18/2011 10:20:13 AM
12
//-->